The September 2022 quarter revenue stood at Rs. 791.32 millions, up 5.94% as compared to Rs. 746.96 millions during the corresponding quarter last year.Net Profit recorded in the quarter ended September 2022 rise to 37.32% to Rs. 130.63  millions  compared to R. 95.13 millions in corresponding previous quarter.Operating profit for the quarter ended September 2022 rose to 258.93 millions as compared to 197.58 millions of corresponding quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 791.32 746.96 5.94 1578.16 1357.01 16.30 2759.80 2090.51 32.02
Other Income 7.71 1.30 493.08 16.71 3.11 437.30 14.54 8.10 79.51
PBIDT 258.93 197.58 31.05 506.39 366.26 38.26 812.26 535.01 51.82
Interest 7.99 2.42 230.17 17.43 6.74 158.61 14.96 21.67 -30.96
PBDT 250.94 182.92 37.19 488.96 347.28 40.80 785.06 513.34 52.93
Depreciation 75.32 54.80 37.45 147.39 109.73 34.32 231.58 229.37 0.96
PBT 175.62 128.12 37.07 341.57 237.55 43.79 553.48 283.97 94.91
TAX 44.99 32.99 36.37 90.64 61.37 47.69 142.90 71.37 100.22
Deferred Tax -9.14 -6.93 31.89 -14.80 -12.39 19.45 -10.33 -4.89 111.25
PAT 130.63 95.13 37.32 250.93 176.18 42.43 410.58 212.60 93.12
Equity 44.22 44.22 0.00 44.22 44.22 0.00 44.22 44.22 0.00
PBIDTM(%) 32.72 26.45 23.70 32.09 26.99 18.89 29.43 25.59 15.00

Vimta Labs Share Price

1069.70 48.60 (4.76%)
29-Apr-2025 11:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1825.05
Dr. Reddys Lab 1180.00
Cipla 1545.55
Lupin 2082.05
Zydus Lifesciences 889.95
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...